S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › FDS › Research report
← FDS page
XStocksXray
Research report · 16 October 2026

Factset Research Systems Inc (FDS)

Financials · Financial Exchanges & Data · US stock · price as of 16 Oct 2026

Key indicators

Price$301.67
52-week range$182.47 – $320.48
Market cap$10.9B
P/E (trailing)19.9×
EV / EBITDA13.4×
Free-cash-flow yield6.5%
Dividend yield1.5%
Revenue (last 12 months)$2.4B
Revenue growth (3y a year)8.0%
Operating margin29.6%
Return on invested capital17.8%
Net debt / EBITDA1.4×

Fair value

Blended fair value$425.83 range $342 – $449
Versus priceFair+41% to fair value
Peer multiples$212.15
Fundamentals-adjusted multiple$393.40
10-year DCF (market-scaled)$671.92
Earnings power value (floor, not blended)$222.69
Model uncertaintyMedium

X-Ray Score

59/ 100 · High confidence · ahead of 76% of sector peers
Valuation65
Growth51
Profitability71
Financial health46
Dividends56

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

170252335417500Fair value $4262021-102023-012024-042025-072026-10

Executive summary

FactSet provides financial data, analytics and software to investment professionals. Its subscription platform combines market data, company information, portfolio tools and research workflows used by asset managers, banks, wealth advisors and corporate clients. Revenue comes mostly from recurring subscription contracts that renew on a regular basis, so results depend on the number of users, the products they take up and the clients' retention.

The company reported revenue of $2.4 billion for the last twelve months. Revenue growth over three years averaged 8.0% a year. Operating margin is 29.6% and return on invested capital is 18%. Net debt to EBITDA is 1.4 times. It pays a dividend with a yield of 1.5%. These figures describe past results as reported and are a factual snapshot, not a forecast. Some measures, such as margins for real estate trusts and banks, are defined differently from those of industrial firms, so comparisons should be made with care.

StocksXray gives Factset Research Systems Inc an X-Ray Score of 59 out of 100 (high confidence), ahead of 76% of the S&P 500 stocks in its sector. Its strongest lens is profitability (71) and its weakest is financial health (46).

Our fair value blend is $425.83 (range $342.22 to $448.75). At $301.67 the stock trades 29% below that blend, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Factset Research Systems Inc (FDS)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$360.26$413.99$420.65$411.39$366.75$301.67
Market cap$13.9B$16.0B$16.4B$15.9B$14.1B$10.9B
P/E34.8×40.4×34.9×29.6×23.6×19.9×
EV / revenue8.6×9.5×8.4×7.6×6.5×4.9×
EV / EBITDA25.5×31.1×23.8×20.3×16.7×13.4×
Price / free cash flow28.1×32.9×28.0×25.8×22.8×15.4×
Free-cash-flow yield3.6%3.0%3.6%3.9%4.4%6.5%
Price / book13.7×12.0×10.1×8.3×6.4×5.4×
Dividend yield–––––1.50%

Fundamentals checklist ● 5 Good · ● 9 Average · ● 2 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−6.3%Good
Free-cash-flow yield6.5%Average

Risk models

Altman Z score3.6×Good
Piotroski F-Score7 of 9Average

Growth

EPS growth (3y)14.9%Average
Free-cash-flow growth (3y)8.2%Average
Revenue growth (3y)8.0%Average
Growth consistency100%Good

Balance sheet

Current ratio0.7×Bad
Net debt / EBITDA1.4×Average
Interest cover13.6×Bad

Valuation

Fair value vs price1.4×Good
EBIT / EV yield5.9%Average

Profitability

Return on invested capital17.8%Average
Operating margin29.6%Average
Gross profitability29.9%Good
stocksxray.com · page 2
XStocksXray
Factset Research Systems Inc (FDS)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue1,5911,8442,0862,2032,3222,438
Gross profit8059731,1121,1911,2241,253
Operating income474475629701748721
Net income400397468537597566
Diluted EPS ($)10.3610.2512.0413.9115.5515.17
Free cash flow494487585615617708
Gross margin50.6%52.8%53.3%54.1%52.7%51.4%
Operating margin29.8%25.8%30.2%31.8%32.2%29.6%
Net margin25.1%21.5%22.4%24.4%25.7%23.2%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets2,2254,0143,9634,0554,3044,192
Cash682503425423338288
Total debt5751,9821,6131,3661,3681,390
Equity1,0161,3311,6201,9122,1862,032
Dividend per share ($)–––––4.46

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%18%36%54%FY21FY22FY23FY24FY25

Latest quarters

Feb 2025May 2025Aug 2025Nov 2025Feb 2026May 2026
Revenue ($M)571586597608611623
Growth vs a year earlier+4.5%+5.9%+6.2%+6.9%+7.1%+6.4%
Net income ($M)145149154153133127
Diluted EPS ($)3.763.87–4.063.593.50
stocksxray.com · page 3
XStocksXray
Factset Research Systems Inc (FDS)

Peers in Financial Exchanges & Data

CompanyX-Ray
FDS · Factset Research Systems I...59
CBOE · Cboe Global Markets, Inc.64
MCO · Moodys Corp62
MSCI · MSCI Inc.56
SPGI · S&P Global Inc.51

Market Compass outlook for Financials: Favourable (72/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+5.0%
1 month+8.2%
3 months+18.4%
6 months+30.7%
1 year+8.1%
3 years−31.5%
5 years−20.6%

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyBullish8 bullish · 1 neutral · 3 bearish
MonthlyNeutral3 bullish · 1 neutral · 4 bearish
50-day / 200-day average$285.43 / $247.36
52-week low / high$182.47 / $320.48
Classic pivot, support and resistanceS2 288.21 · S1 294.94 · P – · R1 309.20 · R2 316.73

Recent dividends

Ex-dividend dateAmount per share
31 Aug 2026$1.1600
29 May 2026$1.1600
27 Feb 2026$1.1000
28 Nov 2025$1.1000
29 Aug 2025$1.1000
30 May 2025$1.1000
stocksxray.com · page 4
XStocksXray
Factset Research Systems Inc (FDS)

Strengths

  • Piotroski F-Score of 7 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Current ratio is weak against Financials peers (0.7×).
  • Interest cover is weak against Financials peers (13.6×).

Latest SEC filings

DateFormItems
30 Sep 20268-K2.02,5.03,9.01
25 Sep 20268-K5.02,9.01
31 Aug 20268-K1.01,2.03,9.01
1 Jul 202610-Q
1 Jul 20268-K2.02,9.01
8 Apr 20268-K5.02,9.01
2 Apr 202610-Q
31 Mar 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026